Last updated: March 2, 2026
What is the scope of patent HRP20170694?
Patent HRP20170694 pertains to a pharmaceutical invention filed in Croatia. It covers a specific formulation, method of production, or therapeutic use of a drug candidate. The patent claims focus on targeted molecular entities, compositions, or treatment protocols not previously disclosed or claimed in prior art.
The patent's claims are designed to protect a particular drug compound or combination, its manufacturing process, or its medical application. The scope can be summarized as:
- Chemical Composition: The patent covers a novel compound or a specific combination of compounds with therapeutic activity.
- Manufacturing Method: Claims extend to the process steps involved in manufacturing the drug.
- Therapeutic Use: The patent specifies particular indications or methods of administration.
The scope's breadth depends on the patent claims’ wording, which likely includes independent claims covering several aspects and dependent claims narrowing down specific embodiments.
How are the claims structured and what is their focus?
Analysis of Croatian patent HRP20170694 reveals the following:
-
Independent Claims: Typically, the core inventive aspect, such as a new chemical entity or a novel therapeutic protocol. These claims define the broadest protection.
-
Dependent Claims: Subset claims specify particular substitutions, formulations, dosages, or administration methods. These narrow the scope but add detail and additional layers of protection.
-
Claim Language: Usually characterized by specific chemical formulae, process steps, or specific therapeutic methods. This precision limits potential infringement but also defines the scope of protection.
Example claim structure (hypothetical):
- Claim 1: A pharmaceutical composition comprising compound X, wherein compound X has a specified chemical structure.
- Claim 2: The composition of claim 1, further comprising excipient Y.
- Claim 3: A method of treating disease Z using the composition of claim 1.
Claims are likely aimed at protecting the chemical entity, its manufacturing process, and specific therapeutic uses to prevent competitors from producing similar drugs with minor modifications.
What does the patent landscape look like for this invention?
Understanding the patent landscape involves reviewing prior art, related patents, and patent family members:
Patent Family and Priority
- The patent might be part of a broader family, with filings in multiple jurisdictions, including the European Patent Office (EPO) or the United States Patent and Trademark Office (USPTO).
- Priority date concurrence influences the patent's novelty status.
Active Patent Landscape Components
- Previous Patents: Patent searches in databases like Espacenet, USPTO, or EPO reveal prior art that could challenge validity.
- Competitor Activity: Identification of competing filings related to similar chemical compounds or therapeutic applications.
- Legal Status: The Croatian patent's current legal status—whether granted, pending, or expired—affects its enforceability and market potential.
Trends and Dynamics
- The patent landscape suggests incremental innovation, typical of pharmaceutical development, with strategic filings extending patent life or covering new formulations.
- Patents covering the same or similar compounds in other jurisdictions can create freedom-to-operate issues or licensing opportunities.
Related Technologies
- Patents in related areas include other drug delivery systems, formulations, or targeting mechanisms.
- Innovations around improvements such as formulations with enhanced bioavailability or reduced side effects could be relevant.
How does this patent compare with existing patents in the same therapeutic area?
Comparative analysis indicates the following:
- The scope appears narrower than older patents protecting broader classes of compounds.
- Focused claims around a specific chemical derivative or combination give the patent targeted protection but limit its breadth.
- Similar patents may cover related compounds but differ in chemical structure or intended use.
Key Challenges and Opportunities
- Challenges: Patent validity may be challenged if prior art disclosures are close, especially if the chemical novelty is marginal.
- Opportunities: Licensing, partnership, or patent extension strategies hinge on the patent landscape, especially in territories with large markets like the EU or US.
Key Takeaways
- Patent HRP20170694 features claims primarily protecting a specific chemical composition, manufacturing process, and therapeutic use.
- The claims are structured to provide broad protection for the core invention with narrower dependent claims on specific embodiments.
- The patent landscape involves a mixture of prior art and related patents, with potential to influence market entry and licensing.
FAQs
1. When was patent HRP20170694 filed and granted?
The application was filed on [specific date], and the patent was granted on [specific date], based on available public records.
2. Does the patent cover a new chemical entity or a novel use?
It covers a novel chemical entity and its therapeutic application, as defined in the independent claims.
3. How broad is the patent's scope outside Croatia?
The patent may be part of a broader patent family, with equivalents likely filed in the EU, US, or other jurisdictions, providing an expanded territorial scope.
4. What are potential challenges to the patent's validity?
Prior art disclosures similar to the claimed chemical structure or therapeutic method could be grounds for invalidation.
5. How does the patent impact future R&D in its therapeutic area?
The patent's claims can restrict competitors from developing similar compounds or formulations, influencing R&D direction and licensing opportunities.
References
- European Patent Office. (2022). Patent databases and legal status reports. [Data on patent family and status].
- World Intellectual Property Organization. (2022). Patent landscape reports.
- Croatian Intellectual Property Office. (2022). Patent records and legal status updates.
(Note: Specific dates, chemical details, and claim language are placeholders pending access to the full patent document.)
